Disruption of thromboxane A2 receptor gene diminishes atherosclerosis in apo E-deficient mice.

被引：0
|
作者：
Kobayashi, T [1 ]
Matsumoto, M [1 ]
Tahara, Y [1 ]
Narumiya, S [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med Sci, Dept Pharmacol, Kyoto 6068501, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2003年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：83P / 83P
页数：1
相关论文
共 50 条
  • [1] Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice
    Cyrus, T
    Witztum, JL
    Rader, DJ
    Tangirala, R
    Fazio, S
    Linton, MF
    Funk, CD
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11): : 1597 - 1604
  • [2] Disruption of thromboxane A2 receptor gene prevents atherosclerosis in apoE-deficient mice
    Matsumoto, M
    Tahara, Y
    Kobayashi, T
    Narumiya, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 267P - 267P
  • [3] Thromboxane A2 receptor in monocyte/macrophages does not affect atherosclerosis in apolipoprotein E-deficient mice
    Zhuge, X
    Arai, H
    Xu, Y
    Kobayashi, T
    Narumiya, S
    Kita, T
    Yokode, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E19 - E20
  • [4] BM-573, a thromboxane receptor antagonist, reduces development of atherosclerosis in apo E-deficient mice
    Cherdon, C.
    Rolin, S.
    Hanson, J.
    Drion, P. V.
    De Leval, L.
    Defraigne, J. O.
    Dogne, J. M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S33 - S34
  • [5] Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice
    Singh, Nikhlesh K.
    Kotla, Sivareddy
    Dyukova, Elena
    Traylor, James G., Jr.
    Orr, A. Wayne
    Chernoff, Jonathan
    Marion, Tony N.
    Rao, Gadiparthi N.
    NATURE COMMUNICATIONS, 2015, 6
  • [6] Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice
    Nikhlesh K. Singh
    Sivareddy Kotla
    Elena Dyukova
    James G. Traylor Jr.
    A. Wayne Orr
    Jonathan Chernoff
    Tony N. Marion
    Gadiparthi N. Rao
    Nature Communications, 6
  • [7] Humoral immunity accelerates atherosclerosis in apolipoprotein E-deficient mice.
    Dansky, HM
    Barlow, CB
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 713 - 713
  • [8] The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis
    Cayatte, AJ
    Du, Y
    Oliver-Krasinski, J
    Lavielle, G
    Verbeuren, TJ
    Cohen, RA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (07) : 1724 - 1728
  • [9] Homozygous disruption of Pctp modulates atherosclerosis in apolipoprotein E-deficient mice
    Wang, Wen-Jun
    Baez, Juan M.
    Maurer, Rie
    Dansky, Hayes M.
    Cohen, David E.
    JOURNAL OF LIPID RESEARCH, 2006, 47 (11) : 2400 - 2407
  • [10] Tolerability of phytosterols in apo E-deficient mice
    Moghadasian, MH
    McManus, BM
    Frohlich, JJ
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 129 - 129
12345